Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis (Q74449293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

cytomegalovirus retinitis

10 November 2019

main subject

1 reference

1 reference

M E Akler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D W Johnson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

W J Burman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S C Johnson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

651-657

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Advances in the management of AIDS-related cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Human immunodeficiency virus type 1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2994019-2

7 January 2021

10.1016/S0161-6420(98)94019-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9544639%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference